Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human ALDH1A1 ELISA Kit (AC2831)
Cat.#: ASET-1420
Specifications
Description Human ALDH1A1 ELISA Kit allows for the in vitro quantitative determination of human ALDH1A1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.938 mIU/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.563-100 mIU/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1670 Human Histidine Decarboxylase ELISA Kit (AC3081) Quantitative inquiry ASET-2372 Human GABA A Receptor alpha 1 ELISA Kit (AC3783) Quantitative inquiry ASET-2324 Mouse SEMA3D ELISA Kit (AC3735) Quantitative inquiry ASET-1582 Canine beta Nerve Growth Factor ELISA Kit (AC2993) Quantitative inquiry ASET-1771 Rat Neuroglobin ELISA Kit (AC3182) Quantitative inquiry ASET-1730 Human Caspase-12 ELISA Kit (AC3141) Quantitative inquiry ASET-1761 Human MAPK ELISA Kit (AC3172) Quantitative inquiry ASET-2200 Mouse PGRPS ELISA Kit (AC3611) Quantitative inquiry ASET-1734 Mouse GDF11 ELISA Kit (AC3145) Quantitative inquiry ASET-2299 Human FGF13 ELISA Kit (AC3710) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket